bioAffinity Technologies
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,510 | $1,351 | $1,592 | $1,446 |
Gross Profit | -3,334 | 308 | 301 | 390 |
EBITDA | -3,292 | -3,501 | -2,997 | -4,929 |
EBIT | -3,354 | -3,615 | -3,121 | -5,042 |
Net Income | -3,366 | -3,630 | -3,137 | -5,051 |
Net Change In Cash | 1,510 | 1,351 | 1,592 | 1,446 |
Free Cash Flow | -3,291 | -3,232 | -2,498 | -2,476 |
Cash | 2,429 | 3,098 | 6,449 | 7,669 |
Basic Shares | 348 | 299 | 114 | 71 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $6,161 | $9,362 | $2,532 | $4 |
Gross Profit | 1,430 | 3,379 | 791 | 4 |
EBITDA | -14,316 | -8,330 | -7,629 | -5,608 |
EBIT | -14,821 | -8,935 | -7,878 | -5,619 |
Net Income | -14,909 | -9,040 | -7,937 | -8,154 |
Net Change In Cash | 6,161 | 9,362 | 2,532 | 4 |
Free Cash Flow | -9,389 | -7,343 | -6,060 | -4,290 |
Cash | 6,449 | 1,105 | 2,821 | 11,413 |
Basic Shares | 114 | 26 | 19 | 9 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.64 |
2026-03-31 | -$0.81 |
2025-12-31 | -$10.46 |
2025-09-30 | -$4.74 |